Heidelberg Pharma AG

10/01/2024 | Press release | Distributed by Public on 10/01/2024 09:37

PR: Heidelberg Pharma: New Clinical Data on Lead ADC Candidate HDP-101 Presented at IMS 2024 Demonstrating Complete Remission in One Patient